Form 4: Criteo CEO Michael Komasinski Awarded 125,000 Shares
Insider Transaction Report
Criteo S.A. CEO and Director Michael Komasinski was granted 125,000 ordinary shares, subject to a multi-year vesting schedule.
Summary
- Michael Komasinski, CEO and Director of Criteo S.A. (CRTO), acquired 125,000 Ordinary Shares.
- The transaction date for this acquisition was December 22, 2025.
- The shares were acquired at a price of $0, indicating a grant or award.
- Following this transaction, Komasinski beneficially owns 176,635 Ordinary Shares.
- The shares are subject to time-based vesting: 2/3rds vest on the two-year anniversary of the grant date, and the remaining 1/3rd vests on the three-year anniversary.
- An alternative vesting schedule applies if Criteo converts to a Luxembourg company before the first anniversary of the grant date: 1/3rd vests on the one-year, 1/3rd on the two-year, and 1/3rd on the three-year anniversary of the grant date.
Sentiment
Score: 7
Explanation: The grant of shares to the CEO is generally positive as it aligns management's interests with shareholders over the long term. However, it's a routine compensation event rather than a direct investment by the CEO, and the future vesting means the impact is not immediate.
Positives
- The grant of 125,000 shares to the CEO aligns management's interests with long-term shareholder value through a multi-year vesting schedule.
- The transaction increases the CEO's direct beneficial ownership in the company to 176,635 shares, demonstrating continued commitment.
Negatives
- The shares are subject to a future vesting schedule, meaning the CEO does not immediately gain full ownership or liquidity of the granted shares.
Risks
- The vesting of the shares is contingent on time-based conditions, and potentially on a corporate conversion to a Luxembourg company, introducing a degree of uncertainty regarding the timing of full ownership.
- Future share price performance will impact the ultimate value of these granted shares to the CEO.
Future Outlook
The grant of shares with a multi-year vesting schedule indicates a long-term commitment from the CEO and ties a portion of his compensation to the company's future performance. The alternative vesting schedule tied to a potential conversion to a Luxembourg company suggests a strategic corporate action may be contemplated in the near future.
Management Comments
- The transaction reflects an equity award to Michael Komasinski, aligning his incentives with the company's long-term strategic goals and shareholder value creation.
Industry Context
Equity grants to executive leadership are a standard practice across the technology and advertising industries to incentivize long-term performance and retain key talent. This grant to Criteo's CEO is consistent with typical executive compensation structures aimed at fostering alignment with shareholder interests.
Comparison to Industry Standards
- Executive equity grants with multi-year vesting schedules are a common compensation tool in the tech sector, similar to practices at companies like Google, Meta, or Adobe, which use such awards to retain top talent and align executive incentives with long-term company performance.
- The $0 acquisition price is typical for performance-based or time-based restricted stock unit (RSU) grants, which are prevalent in publicly traded companies as a non-cash compensation component.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Potential Corporate Structure Change | The filing references a potential conversion of the Company into a Luxembourg company, which could impact corporate governance structure and legal domicile. | Prior to 12/22/2026 (first anniversary of grant date) | A conversion to a Luxembourg company would likely entail changes to the company's legal framework, potentially affecting shareholder rights, board structure, and regulatory oversight, though specific details are not provided in this filing. |
Related Party Transactions
- The acquisition of shares by Michael Komasinski, CEO and Director, constitutes a related party transaction as it involves an executive officer of the company.
Stakeholder Impact
- Shareholders: The grant aligns the CEO's long-term financial interests with the company's performance, potentially fostering greater commitment to shareholder value creation.
- Employees: May signal stability in leadership and a long-term strategic vision for the company.
Next Steps
- The shares will vest according to the specified schedule on the two-year and three-year anniversaries of the grant date, or potentially on the one-year, two-year, and three-year anniversaries if the company converts to a Luxembourg entity before the first anniversary.
Key Dates
| Date | Description |
|---|---|
| 12/22/2025 | Date of transaction for the acquisition of 125,000 Ordinary Shares. |
| 12/22/2027 | Two-year anniversary of the grant date, when 2/3rds of the shares are scheduled to vest under the standard schedule. |
| 12/22/2028 | Three-year anniversary of the grant date, when the remaining 1/3rd of the shares are scheduled to vest under the standard schedule. |
Recommendation
holdThis Form 4 filing details a routine equity grant to the CEO, which is a standard component of executive compensation and aligns management incentives with long-term shareholder value. While positive for governance and management alignment, it does not present new fundamental information that would significantly alter the investment thesis for Criteo. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while monitoring future operational and financial performance.
Keywords
Criteo, CRTO, Michael Komasinski, CEO, Director, Share Grant, Equity Award, Insider Transaction, Vesting, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.